under the deal, production of the hoodia cactus at phytopharm's nursery in south africa will also rise from eight million plants to potentially hundreds of millions, said phytopharm chief executive richard dixey. but the research collaboration came to an end in 2003. analysts said unilever could launch the new products in 2007. this deal goes a long way to restoring the market faith in phytopharm's pipeline after the pfizer exit, said analyst erling refsum at nomura.